News

How the Supreme Court’s Decision in Amgen v. Sanofi Impacts Pharmaceutical Patents

By: Nafsika Karavida On May 18, 2023, the Supreme Court of the United States (the “Court” or “SCOTUS”) handed down its decision in Amgen Inc. v. Sanofi (“Amgen/Sanofi” or the “Amgen case”) [1] , a fairly notorious case among pharmaceutical companies and patent nerds.  Amgen/Sanofi is about the so-called enablement...

Read More

Copyright Issues as they Pertain to AI and the Visual Arts: Let Us Paint You a Picture

By: Ethan Krasnoo and Anna Beckelman As artificial intelligence (“AI”) becomes more and more prevalent in our everyday use of technology, legal questions are being raised about how AI products are “trained” and how such training may encroach on “human generated” intellectual property. Earlier this year, our Reavis Page Jump...

Read More

RPJ Partner Ethan Krasnoo’s Legal Opinion Featured in Fox Corporation’s News Article “Plaintiff in Robert De Niro Harassment Lawsuit Gets Intimidating Text From His Family: Lawyer”

RPJ’s Ethan Krasnoo recently weighed in on the Robert De Niro Employment Discrimination Lawsuit currently unfolding in court. This Monday, in the midst of the court’s proceedings, a potentially incriminating text message sent by De Niro’s daughter to De Niro’s former assistant, the plaintiff in the ongoing gender discrimination trial...

Read More

New NLRB Rule Broadens Scope of Joint Employment

On October 27, 2023, the National Labor Relations Board (NLRB) published its Final Rule addressing the “Standard for Determining Joint-Employer Status” under the National Labor Relations Act (NLRA).  The new rule, slated to take effect on December 26, 2023, significantly expands the circumstances under which separate businesses can be considered...

Read More